GHRP-6 Research Peptide Overview | Pure Lab Peptides
GHRP-6 (Growth Hormone Releasing Peptide-6) is a synthetic hexapeptide and potent growth-hormone secretagogue that acts on the ghrelin receptor (GHS-R1a) to stimulate GH release【12†L21-L24】. In laboratory research, GHRP-6 is used to probe endocrine and metabolic pathways, including GH axis signaling and cytoprotective mechanisms. This overview defines GHRP-6, summarizes its biological effects in preclinical studies, and reviews analytical and documentation considerations. All compounds discussed are intended for research use only.
Fast Answer
Products discussed in this article are intended for laboratory research use only and are not intended for human or animal consumption. GHRP-6 is a synthetic peptide that acts as a growth hormone secretagogue by binding the GHS-R1a receptor【12†L21-L24】. In preclinical studies it is used to investigate GH axis signaling, metabolic regulation, and cell survival pathways in research models.
GHRP-6 Overview
GHRP-6 was developed in the 1980s as one of the first synthetic growth hormone-releasing peptides【12†L21-L24】. It is a six-amino-acid peptide (sequence His-D-Trp-Ala-Trp-D-Phe-Lys, abbreviated HWAWFK【28†L195-L203】) that mimics the action of ghrelin and growth-hormone-releasing hormone (GHRH). GHRP-6 belongs to the GH secretagogue family and binds the ghrelin receptor (GHS-R1a) on pituitary cells【12†L21-L24】. In animal studies, GHRP-6 reliably increases GH secretion and downstream IGF-1 activity【28†L161-L169】. Its synthetic nature and well-defined sequence make GHRP-6 a useful tool peptide for endocrinology and metabolic research rather than any therapeutic use.
Mechanism of Action
GHRP-6 acts by engaging cell-surface receptors to trigger hormonal and survival pathways. It binds the GHS-R1a receptor (a G-protein–coupled receptor) on somatotropes and other cells, activating a Gq/11-mediated cascade【30†L169-L177】. This leads to phospholipase C activation, production of IP3 and DAG, and a rise in intracellular Ca2+, which promotes GH release from the pituitary. Additionally, GHRP-6 (like other GHRPs) can bind the CD36 scavenger receptor【30†L169-L177】. CD36 engagement triggers PI3K/AKT signaling, enhancing cell survival and reducing oxidative stress. Overall, GHRP-6’s dual receptor activity (GHS-R1a and CD36) links it to both endocrine regulation and prosurvival pathways【30†L169-L177】.
Figure: Schematic of GHRP-6 action. GHRP-6 binds GHS-R1a to trigger GH release via a Gq/PLC/Ca2+ pathway, and also engages CD36 to activate PI3K/AKT survival signaling.
Applications in Research
Researchers use GHRP-6 to study the growth hormone axis, metabolism, and tissue protection in preclinical models. Because it synergizes with GHRH, GHRP-6 raises GH levels additively【12†L21-L24】, making it a probe for somatotropic regulation. Studies in metabolic disease models show GHRP-6 can mimic ghrelin’s pro-motility effects; for example, it accelerated gastric emptying in diabetic mice【48†L241-L246】. It has also been applied in organ-injury models: for instance, GHRP-6 reduced inflammation and fibrosis in mouse lung injury【17†L325-L331】 and improved renal recovery in ischemic kidney injury【28†L161-L169】. In vitro, GHRP-6 has been reported to enhance cell migration and survival, consistent with its CD36-mediated prosurvival signaling【30†L169-L177】. These findings illustrate GHRP-6’s utility as a research compound for studying GH-dependent processes, metabolic regulation, and protective mechanisms in laboratory settings.
Quality and Documentation
As a research-use-only peptide, GHRP-6 should be accompanied by detailed batch documentation. Key elements include a lot-specific Certificate of Analysis (COA) with results from orthogonal tests. Purity is typically assessed by reversed-phase HPLC (e.g. >95% purity) and identity is confirmed by mass spectrometry (matching the expected peptide mass). Regulators and experts emphasize that purity (the fraction of material that is GHRP-6) and identity (confirmation of the HWAWFK sequence) are distinct concepts【56†L110-L116】. Laboratory users should verify that the COA provides chromatograms, MS spectra, and traceable methods. Additional information on peptide-specific terminology and documentation can be found in resources like our guides on peptide purity vs identity and storage handling. For example, peptide storage recommendations often link to stability guidelines (see peptide storage and handling) to ensure that GHRP-6 remains intact under defined conditions【54†L99-L107】.
Preclinical Evidence
GHRP-6 has been examined in diverse preclinical studies. The table below summarizes representative experiments and findings, emphasizing research contexts and outcomes in laboratory models.
| Study | Model / Context | Key Findings |
| Wang et al. 2026 [4] | Mouse acute lung injury (LPS/Zymosan model) | GHRP-6 treatment reduced lung inflammation, preserved alveolar integrity, and decreased collagen deposition in both acute and fibrotic phases【17†L325-L331】. |
| Zhao et al. 2026 [3] | Mouse acute kidney injury (ischemia model) | GHRP-6 hydrogel enhanced renal cell survival and metabolic recovery, promoting tissue repair and function after AKI【28†L161-L169】. |
| Zheng et al. 2008 [5] | Diabetic mouse model | GHRP-6 accelerated gastric emptying and improved intestinal transit, demonstrating prokinetic effects via ghrelin receptor activation【48†L241-L246】. |
FAQs
What is GHRP-6 and how is it used in research?
GHRP-6 is a synthetic growth hormone secretagogue peptide studied in laboratory research. It binds the ghrelin receptor (GHS-R1a) to stimulate GH release【12†L21-L24】. In research, GHRP-6 is used to investigate growth hormone signaling, metabolic regulation, and protective pathways in cells or animal models. All uses are strictly for research; it is not intended for clinical or human application.
Which receptors does GHRP-6 target?
GHRP-6 primarily targets the GHS-R1a receptor (the ghrelin receptor) on pituitary and other cells, triggering intracellular signaling that leads to GH secretion【30†L169-L177】. It also binds the CD36 scavenger receptor, activating PI3K/AKT survival pathways【30†L169-L177】. These interactions are studied to understand how GH release and cell-protective signals are regulated by the peptide in research settings.
How is the quality of a GHRP-6 peptide verified?
Quality evaluation of GHRP-6 involves confirming its identity and purity. Identity is confirmed by mass spectrometry or peptide mapping to match the expected sequence (HWAWFK). Purity is assessed by analytical HPLC, reporting the fraction of material that is GHRP-6【56†L110-L116】. A proper Certificate of Analysis will document these tests along with batch information. Researchers should consult documentation (COA) to verify peptide specifications and ensure they are working with a correctly identified RUO compound.
Can GHRP-6 be used in humans or animals?
No. GHRP-6 is supplied as research-use-only material. It is not formulated, tested, or approved for any clinical or veterinary use. All discussion of GHRP-6 in this article is restricted to laboratory and preclinical research contexts, and the product labeling emphasizes that it is not for human or animal consumption.
How do researchers measure GHRP-6’s effects in experiments?
Researchers may measure GH levels in cell culture media or animal serum after GHRP-6 exposure, using immunoassays for GH or IGF-1 as readouts. They also examine cellular responses such as receptor activation or signaling markers (e.g. phosphorylation of AKT) via Western blot or ELISA. In vivo models may track physiological readouts like gastric emptying rates or tissue recovery metrics to study the peptide’s effects【48†L241-L246】【17†L325-L331】.
What documentation should accompany a GHRP-6 purchase?
Researchers should receive a lot-specific Certificate of Analysis from the supplier, detailing peptide identity, purity, and analytical data. The documentation should include batch/lot numbers, HPLC chromatograms, mass spectrometry data, and any relevant metadata. It should clearly label the product as GHRP-6 (His-D-Trp-Ala-Trp-D-Phe-Lys) and state that it is research-use-only. If documentation is unclear, researchers are encouraged to contact the supplier for clarification.
Next Steps
Always review the batch-specific Certificate of Analysis before working with any GHRP-6 peptide. Pure Lab Peptides provides RUO peptides with transparent labeling and documentation. For research teams comparing suppliers, prioritize sources that offer clear COAs, traceable lot data, and research-focused product information to ensure quality and compliance in your studies.
References
- Cao JM, Chen C. “Effects of ghrelin and synthetic GH secretagogues on the cardiovascular system.” Trends Endocrinol Metab. 2006;17(1):13-18. doi.org/10.1016/j.tem.2005.11.004
- Berlanga-Acosta J, Abreu-Cruz A, García-del Barco Herrera D, et al. “Synthetic Growth Hormone-Releasing Peptides (GHRPs): A Historical Appraisal of the Evidences Supporting Their Cytoprotective Effects.” Clin Med Insights Cardiol. 2017;11:1179546817694558. doi.org/10.1177/1179546817694558
- Zhao X, Pan K, Li R, et al. “Growth hormone-releasing peptide 6 (GHRP-6) hydrogel for acute kidney injury therapy via metabolic regulation.” J Nanobiotechnol. 2026;24:15. doi.org/10.1186/s12951-025-03888-9
- Wang L, Berlanga-Acosta J, Valenzuela-Silva C, et al. “Growth hormone releasing peptide-6 (GHRP-6) ameliorates acute lung injury and its subsequent evolvement to interstitial fibrosis.” Int Immunopharmacol. 2026;172:116204. doi.org/10.1016/j.intimp.2026.116204
- Zheng Q, Qiu WC, Yan J, et al. “Prokinetic effects of a ghrelin receptor agonist GHRP-6 in diabetic mice.” World J Gastroenterol. 2008;14(30):4795-4800. doi.org/10.3748/wjg.14.4795